Search Results 201-210 of 17513 for Bronchodilators

1. Methacholine (inhalation route) - Side effects & uses - Mayo Clinic

   Description. Methacholine inhalation is used to help your doctor diagnose bronchial airway hyperreactivity or asthma. This medicine works by narrowing your ...

2. Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors - Mayo Clinic

   Patients that require intermittent use of bronchodilators, topical steroids or local steroid injections will not be excluded from the study. Patients who ...

3. A Study To Evaluate Efficacy, Safety And Tolerability Of CK-2127107 In Patients With Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

   Chronic obstructive pulmonary disease or asthma requiring daily use of bronchodilator medications;; Gastrointestinal disorder that is likely to impair ...

4. A Study To Validate Patient-Reported Outcome Instruments In Adult Subjects With Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection - Mayo Clinic

   Predicted forced expiratory volume in 1 second (FEV1) < 35%, pre-bronchodilator use. Current smoker. History of lung transplantation. Use of inhaled or ...

5. Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping - Mayo Clinic

   Evidence of asthma demonstrated by either bronchodilator reversibility (either at screening or by historical evidence) or methacholine responsiveness (by ...

6. An issue with how blood flows in the heart. Changes in the protein called hemoglobin, which carries oxygen in red blood cells. Causes of hypoxemia that are ...

7. Anesthesiology and Perioperative Medicine - Doctors - Mayo Clinic

   ... Bronchodilator therapy. Show more areas of focus for Kevin H. Luk, M.D.. OverviewSpecialty groups. Aug. 20, 2025. Share on: FacebookTwitter. Anesthesiology and ...

8. Evaluate The Effect Of Aclidinium Bromide On Long-term Cardiovascular Safety And Exacerbations In Moderate To Very Severe COPD Patients. - Mayo Clinic

   ... bronchodilator FEV < 80% FEV1/forced vital capacity (FVC) ratio < 70%; 4. Must have at least one of the following 4 criteria: Documented cerebrovascular ...

9. GS-4997 In Adults With Pulmonary Arterial Hypertension - Mayo Clinic

   Meet the following criteria determined by pulmonary function tests completed no more than 24 weeks prior to screening, performed with or without bronchodilation ...

10. A Study To Evaluate The Use Of MANP In Patients With Hypertension And Metabolic Syndrome - Mayo Clinic

    Oral or inhaled sympathomimetics (β-agonists) bronchodilators and over the counter cold/decongestant products that contain a β-agonist are NOT allowed within 48 ...